BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Three New Executive Team Leaders

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, has appointed three new seasoned veterans to its leadership team. The company announced that Jason Roth will serve as chief operating officer, Neil Luckianow will serve as chief commercial officer and Anthony Pedicelli will serve as director of marketing. The company noted the new leaders are part of its accelerated global expansion efforts; Jupiter is planning to launch Photocil and other products worldwide following the brand’s acquisition in 2022. Roth has worked for more than 25 years in the consumer packaged goods industry. His experience as founder and executive of global brands such as Zim’s, VeraTemp, ISI, and Mile High Labs will be “the cornerstone of Jupiter’s new proven business model,” said the company. Luckianow has extensive experience in sales/account management, product distribution, trade relations, business development, product promotion and trade marketing. He has worked as a leader several companies, including LifeScan Inc., a Johnson & Johnson company; Amira Medical, Bayer HealthCare’s Diabetes Care Division; and Facet Technologies. His expertise will significantly enhance Jupiter Wellness’s sales and marketing capabilities. Pedicelli has garnered impressive experience in overseeing marketing teams and executing successful marketing programs for multinational medical devices, luxury smart home builders and cannabis companies. Most recently, he served as director of marketing for ISI Group of Companies, where he was key in the company’s achievement of 10x revenue growth. “Jupiter Wellness is excited to welcome these talented and experienced professionals to our leadership team,” said Jupiter Wellness CEO Brian John in the press release. “This addition to the team is exactly what Jupiter was missing. We have great science and a vast product pipeline; we just needed their expertise to effectively get these products into the consumers’ hands. Once this sales and marketing platform is created, it will be invaluable to Jupiter Wellness’s ability to launch new products in the future.”

To view the full press release, visit https://ibn.fm/rBkAm

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program 

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager…

36 minutes ago

BioMedNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Announces Term Sheet for CAD$5 Million Private Placement

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.…

1 day ago

BioMedNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advances ONC010 Manufacturing Development With Nanosoft

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.…

1 day ago

BioMedNewsBreaks — Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans

Cardio Diagnostics Holdings (NASDAQ: CDIO) is a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence.…

2 days ago

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS…

2 days ago

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Publishes Peer-Reviewed Validation of Deciparticle(TM) Platform 

Oncotelic Therapeutics (OTCQB: OTLC), together with Sapu Nano, announced the publication of a peer-reviewed manuscript in the International Journal of…

3 days ago